China
· Delayed Price · Currency is CNY Shijiazhuang Yiling Pharmaceutical Statistics
Total Valuation
Shijiazhuang Yiling Pharmaceutical has a market cap or net worth of CNY 26.36 billion. The enterprise value is 26.72 billion.
| Market Cap | 26.36B |
| Enterprise Value | 26.72B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Jul 19, 2024 |
Share Statistics
Shijiazhuang Yiling Pharmaceutical has 1.67 billion shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.67B |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 28.62% |
| Owned by Institutions (%) | 5.89% |
| Float | 665.73M |
Valuation Ratios
The trailing PE ratio is 177.55 and the forward PE ratio is 20.12.
| PE Ratio | 177.55 |
| Forward PE | 20.12 |
| PS Ratio | 3.25 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.61, with an EV/FCF ratio of -9,041.80.
| EV / Earnings | 179.97 |
| EV / Sales | 3.30 |
| EV / EBITDA | 34.61 |
| EV / EBIT | 177.06 |
| EV / FCF | -9,041.80 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.57 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.67 |
| Debt / FCF | -436.89 |
| Interest Coverage | 3.64 |
Financial Efficiency
Return on equity (ROE) is 1.20% and return on invested capital (ROIC) is 0.72%.
| Return on Equity (ROE) | 1.20% |
| Return on Assets (ROA) | 0.55% |
| Return on Capital (ROIC) | 0.72% |
| Revenue Per Employee | 580,963 |
| Profits Per Employee | 10,637 |
| Employee Count | 13,958 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.22% in the last 52 weeks. The beta is 0.20, so Shijiazhuang Yiling Pharmaceutical's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -29.22% |
| 50-Day Moving Average | 17.02 |
| 200-Day Moving Average | 17.30 |
| Relative Strength Index (RSI) | 36.99 |
| Average Volume (20 Days) | 20,996,510 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shijiazhuang Yiling Pharmaceutical had revenue of CNY 8.11 billion and earned 148.47 million in profits. Earnings per share was 0.09.
| Revenue | 8.11B |
| Gross Profit | 4.05B |
| Operating Income | 150.91M |
| Pretax Income | 250.23M |
| Net Income | 148.47M |
| EBITDA | 764.15M |
| EBIT | 150.91M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 916.31 million in cash and 1.29 billion in debt, giving a net cash position of -374.79 million or -0.22 per share.
| Cash & Cash Equivalents | 916.31M |
| Total Debt | 1.29B |
| Net Cash | -374.79M |
| Net Cash Per Share | -0.22 |
| Equity (Book Value) | 11.49B |
| Book Value Per Share | 6.89 |
| Working Capital | 2.25B |
Cash Flow
In the last 12 months, operating cash flow was 333.46 million and capital expenditures -336.42 million, giving a free cash flow of -2.96 million.
| Operating Cash Flow | 333.46M |
| Capital Expenditures | -336.42M |
| Free Cash Flow | -2.96M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 49.96%, with operating and profit margins of 1.86% and 1.83%.
| Gross Margin | 49.96% |
| Operating Margin | 1.86% |
| Pretax Margin | 3.09% |
| Profit Margin | 1.83% |
| EBITDA Margin | 9.42% |
| EBIT Margin | 1.86% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -40.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 482.97% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 0.56% |
| FCF Yield | -0.01% |
Stock Splits
The last stock split was on July 7, 2021. It was a forward split with a ratio of 1.4.
| Last Split Date | Jul 7, 2021 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Shijiazhuang Yiling Pharmaceutical has an Altman Z-Score of 5.16.
| Altman Z-Score | 5.16 |
| Piotroski F-Score | n/a |